Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Myelin oligodendrocyte glycoprotein antibody-associated disease presenting as isolated simultaneous bilateral optic neuritis in a child.

Oman journal of ophthalmology·2026
Same author

Reply to Letter to the Editor.

Oman journal of ophthalmology·2025
Same author

Lessons Learned from Implementing Injury and Illness Surveillance in Professional Football: Introducing a New Implementation Framework.

Sports medicine (Auckland, N.Z.)·2025
Same author

Demographic profile, prevalence, pattern, and risk factors for retinal vein occlusion in Liberia: A retrospective study.

Oman journal of ophthalmology·2024
Same author

Anti-Insulin Receptor Antibody for Malignant Insulinoma and Refractory Hypoglycemia.

The New England journal of medicine·2023
Same author

Postoperative Euglycemic Ketoacidosis in Type 2 Diabetes Associated with Sodium-Glucose Cotransporter 2 Inhibitor: Insights Into Pathogenesis and Management Strategy.

Cureus·2021

Related Experiment Video

Updated: May 27, 2026

Measuring Psoriasis Severity at Home
02:28

Measuring Psoriasis Severity at Home

Published on: March 1, 2024

Cardiovascular comorbiditiy in psoriasis.

Gurcharan Singh1, Simran Pal Singh Aneja

  • 1Department of Dermatology and STD, Sri Devaraj Urs Medical College, Tamaka, Kolar, India.

Indian Journal of Dermatology
|November 29, 2011
PubMed
Summary

Psoriasis, a chronic inflammatory skin disease, increases the risk of cardiovascular and metabolic disorders. Dermatologists must recognize psoriasis as a systemic condition and inform patients about these associated health risks.

Keywords:
Carsiovascular diseasemetabolic syndromepsoriasis

More Related Videos

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
11:39

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on: July 11, 2013

Related Experiment Videos

Last Updated: May 27, 2026

Measuring Psoriasis Severity at Home
02:28

Measuring Psoriasis Severity at Home

Published on: March 1, 2024

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
11:39

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on: July 11, 2013

Area of Science:

  • Dermatology
  • Cardiology
  • Metabolic Disorders

Background:

  • Psoriasis is a chronic inflammatory condition.
  • Chronic inflammation is linked to other systemic diseases.
  • Cardiovascular and metabolic (cardiometabolite) disorders are notable associated conditions.

Purpose of the Study:

  • To highlight the association between psoriasis and cardiometabolic disorders.
  • To emphasize the need for dermatologists to consider psoriasis as a multisystem disorder.
  • To inform patients about the potential negative health effects of psoriasis.

Main Methods:

  • Review of existing studies linking psoriasis to cardiovascular risk factors.
  • Analysis of epidemiological data on comorbidities in psoriasis patients.
  • Clinical observation of patients with psoriasis and associated conditions.

Main Results:

  • Psoriasis is associated with increased prevalence of cardiovascular risk factors including diabetes, obesity, hypertension, and dyslipidemia.
  • Patients with psoriasis have a higher incidence of diseases such as myocardial infarction (MI).
  • The chronic inflammatory nature of psoriasis contributes to the development of cardiometabolic disorders.

Conclusions:

  • Dermatologists should manage psoriasis as a systemic disease due to its association with cardiovascular and metabolic comorbidities.
  • Patients with psoriasis must be educated about the increased risk of cardiometabolic disorders.
  • Early identification and management of risk factors are crucial for patients with psoriasis.